Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions ; volume:15 ; number:1 ; day:5 ; month:3 ; year:2024 ; pages:1-15 ; date:12.2024
Stem cell research & therapy ; 15, Heft 1 (5.3.2024), 1-15, 12.2024
- Creator
-
Herger, Nick
Heggli, Irina
Mengis, Tamara
Devan, Jan
Arpesella, Leonardo
Brunner, Florian
Distler, Oliver
Dudli, Stefan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-024-03677-5
- URN
-
urn:nbn:de:101:1-2405101050224.350646014103
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Herger, Nick
- Heggli, Irina
- Mengis, Tamara
- Devan, Jan
- Arpesella, Leonardo
- Brunner, Florian
- Distler, Oliver
- Dudli, Stefan
- SpringerLink (Online service)
Other Objects (12)
Enhancement of immunosuppressive activity of mesenchymal stromal cells by platelet-derived factors is accompanied by apoptotic priming
Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming
Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells
LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
![Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells
Tuning the Microenvironment to Create Functionally Distinct Mesenchymal Stromal Cell Spheroids
Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals
Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
Enhancement of immunosuppressive activity of mesenchymal stromal cells by platelet-derived factors is accompanied by apoptotic priming
Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming
Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells
LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells
Tuning the Microenvironment to Create Functionally Distinct Mesenchymal Stromal Cell Spheroids
Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals
Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
Enhancement of immunosuppressive activity of mesenchymal stromal cells by platelet-derived factors is accompanied by apoptotic priming
Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming
Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells
LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells
Tuning the Microenvironment to Create Functionally Distinct Mesenchymal Stromal Cell Spheroids
Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals
Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies